Sulfonylurea Compounds

ATP binding cassette subfamily C member 8 ; Homo sapiens







112 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34380876 The short form of the SUR1 and its functional implications in the damaged brain. 2022 Mar 1
2 33184150 Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes. 2021 Jan 5
3 33185579 Transient neonatal diabetes due to a disease causing novel variant in the ATP-binding cassette subfamily C member 8 (ABCC8) gene unmasks maturity-onset diabetes of the young (MODY) diabetes cases within a family. 2021 Feb 23 3
4 33606663 Differences between transient neonatal diabetes mellitus subtypes can guide diagnosis and therapy. 2021 Apr 1
5 33767884 BIIB093 (intravenous glibenclamide) for the prevention of severe cerebral edema. 2021 1
6 34099169 Production and purification of ATP-sensitive potassium channel particles for cryo-electron microscopy. 2021 1
7 34566892 Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of KATP-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital. 2021 1
8 34575427 Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K+ Channels: Role in the Adverse Drug Reactions. 2021 Aug 27 1
9 34744976 Pretreatment of Sulfonylureas Reducing Perihematomal Edema in Diabetic Patients With Basal Ganglia Hemorrhage: A Retrospective Case-Control Study. 2021 1
10 34825567 Photo-Switchable Sulfonylureas Binding to ATP-Sensitive Potassium Channel Reveal the Mechanism of Light-Controlled Insulin Release. 2021 Dec 9 1
11 31562829 Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapy. 2020 May 2
12 31889684 Effectiveness of sulfonylurea treatment in a patient with a mutation in ABCC8 (MODY12). 2020 Dec 1
13 32104032 Recent Advances in Neonatal Diabetes. 2020 1
14 32376986 New insights into KATP channel gene mutations and neonatal diabetes mellitus. 2020 Jul 1
15 32418263 Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype. 2020 Sep 1
16 32468916 Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study. 2020 Jun 1
17 32598150 Structural Determinants of Insulin Release: Disordered N-Terminal Tail of Kir6.2 Affects Potassium Channel Dynamics through Interactions with Sulfonylurea Binding Region in a SUR1 Partner. 2020 Jul 23 2
18 32792356 Molecular and clinical characteristics of monogenic diabetes mellitus in southern Chinese children with onset before 3 years of age. 2020 Aug 1
19 33035187 The use of glimepiride for the treatment of neonatal diabetes mellitus caused by a novel mutation of the ABCC8 gene. 2020 Dec 16 1
20 33102403 Neonatal Diabetes Mellitus. 2020 1
21 33498041 Clinical Characteristics, Molecular Features, and Long-Term Follow-Up of 15 Patients with Neonatal Diabetes: A Single-Centre Experience. 2020 1
22 29396966 Search for Pharmacoepigenetic Correlations in Type 2 Diabetes Under Sulfonylurea Treatment. 2019 Apr 3
23 31196892 Neonatal diabetes mellitus due to a novel variant in the INS gene. 2019 Aug 1
24 31231590 The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetes. 2019 2
25 28791793 Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China. 2018 Mar 1
26 29454299 Congenital forms of diabetes: the beta-cell and beyond. 2018 Jun 1
27 29675256 A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement. 2018 1
28 29681852 Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus. 2018 2
29 29844136 A novel high-affinity inhibitor against the human ATP-sensitive Kir6.2 channel. 2018 Jul 2 1
30 29846255 Monogenic diabetes: the impact of making the right diagnosis. 2018 Aug 1
31 30147301 Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date. 2018 2
32 30637228 Sulfonylurea and neuroprotection: The bright side of the moon. 2018 Oct-Dec 1
33 28411266 Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease. 2017 Aug 1
34 28511139 A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up. 2017 Jul 2
35 28540314 Neonatal Diabetes: Case Report of a 9-Week-Old Presenting Diabetic Ketoacidosis Due to an Activating ABCC8 Gene Mutation. 2017 Jan-Mar 2
36 28587604 KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment. 2017 Jun 6 4
37 29035201 Anti-diabetic drug binding site in a mammalian KATP channel revealed by Cryo-EM. 2017 Oct 24 1
38 27161588 The shifting landscape of KATP channelopathies and the need for 'sharper' therapeutics. 2016 May 1
39 27180666 [Pharmacogenetics of oral antidiabetic treatment]. 2016 Mar 1
40 27329029 Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea. 2016 Jul 1
41 27538677 ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective. 2016 Sep 1
42 27849623 Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation. 2016 Dec 1 2
43 26388896 Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation. 2015 Aug 1
44 26392140 Topical sulfonylurea as a novel therapy for hypertrichosis secondary to diazoxide, and potentially for other conditions with excess hair growth. 2015 Dec 1
45 26767545 Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas? 2015 1
46 24150606 OATP1B3 is expressed in pancreatic β-islet cells and enhances the insulinotropic effect of the sulfonylurea derivative glibenclamide. 2014 Feb 1
47 24468609 A novel activating ABCC8 mutation underlying neonatal diabetes mellitus in an infant presenting with cerebral sinovenous thrombosis. 2014 May 1
48 24849284 Carbamazepine inhibits ATP-sensitive potassium channel activity by disrupting channel response to MgADP. 2014 2
49 25052923 Permanent neonatal diabetes mellitus in China. 2014 Jul 23 1
50 25238204 Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. 2014 Dec 1